We will work closely with you and your healthcare provider to evaluate factors such as your overall health, risk of weight regain, and any underlying conditions that may benefit from continued GLP-1 use
Marx N, Federici M, Schtt K et al (2023) 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

Europe By Product By Dosage Form By Age Group By Channel Market Attractiveness Analysis By Country By Product By Dosage Form By Age Group By Channel Key Takeaways East Asia Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country Historical Market Size Value (USD Billion) & Volume (Million Units) Trend Analysis By Market Taxonomy, 2020 to 2024 Market Size Value (USD Billion) & Volume (Million Units) Forecast By Market Taxonomy, 2025 to 2035 By Country China Japan South Korea By Product By Dosage Form By Age Group By Channel Market Attractiveness Analysis By Country By Product By Dosage Form By Age Group By Channel Key Takeaways South Asia & Pacific Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country Historical Market Size Value (USD Billion) & Volume (Million Units) Trend Analysis By Market Taxonomy, 2020 to 2024 Market Size Value (USD Billion) & Volume (Million Units) Forecast By Market Taxonomy, 2025 to 2035 By Country India Australia & New Zealand ASEAN Rest of SAP By Product By Dosage Form By Age Group By Channel Market Attractiveness Analysis By Country By Product By Dosage Form By Age Group By Channel Key Takeaways Middle East and Africa Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country Historical Market Size Value (USD Billion) & Volume (Million Units) Trend Analysis By Market Taxonomy, 2020 to 2024 Market Size Value (USD Billion) & Volume (Million Units) Forecast By Market Taxonomy, 2025 to 2035 By Country GCC Countries Northern Africa South Africa Turkiye Rest of MEA By Product By Dosage Form By Age Group By Channel Market Attractiveness Analysis By Country By Product By Dosage Form By Age Group By Channel Key Takeaways Key Countries Market Analysis USA Pricing Analysis Market Share Analysis, 2024 By Product By Dosage Form By Age Group By Channel Canada Pricing Analysis Market Share Analysis, 2024 By Product By Dosage Form By Age Group By Channel Brazil Pricing Analysis Market Share Analysis, 2024 By Product By Dosage Form By Age Group By Channel Mexico Pricing Analysis Market Share Analysis, 2024 By Product By Dosage Form By Age Group By Channel Argentina Pricing Analysis Market Share Analysis, 2024 By Product By Dosage Form By Age Group By Channel Market Structure Analysis Competition Dashboard Competition Benchmarking Market Share Analysis of Top Players By Regional By Product By Dosage Form By Age Group By Channel Competition Analysis Competition Deep Dive Nestl Health Science Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Herbalife Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Unjury Protein Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy ProCare Health Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy FullWell Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy The Vitamin Shoppe Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy SOLO TREE Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Replenza Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy KetoZest Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Keptropy Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Abbott Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Vital Nutrients Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Natnect Overview Product Portfolio Profitability by Market Segments (Product/Age /Sales Channel/Region) Strategy Overview Marketing Strategy Product Strategy Channel Strategy Assumptions & Acronyms Used Research Methodology

Adipose tissue inflammation and metabolic dysfunction in obesity
Eligibility will likely include Medicare beneficiaries who qualify for GLP-1 medications like Wegovy and Zepbound
Its also worth noting that the oral drugs in the kits have been shown to produce more modest weight loss results compared to the Wegovy pill and Foundayo , which are FDA-approved pills specifically for weight loss